73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
70-gene signature impacts treatment decisions in breast CA

70-gene signature impacts treatment decisions in breast CA

(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a stud

70-gene signature impacts treatment decisions in breast CA

(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a stud
Researchers discover new genetic link to premenopausal breast cancer

Researchers discover new genetic link to premenopausal breast cancer

by University of Alberta Faculty of Medicine & DentistryGraduate student Mahalakshmi Kumaran (left) and professor Sambasivarao Damaraju led a team that discovered a new genetic marker linked

Researchers discover new genetic link to premenopausal breast cancer

by University of Alberta Faculty of Medicine & DentistryGraduate student Mahalakshmi Kumaran (left) and professor Sambasivarao Damaraju led a team that discovered a new genetic marker linked
Prostate cancer: Can AI help to avoid unnecessary biopsies?

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o
Long-term cardiomyopathy risk varies by chemo agent

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe
Researcher helps define subtypes of ovarian cancer

Researcher helps define subtypes of ovarian cancer

by The City University of New YorkCredit: CC0 Public DomainIn a new paper published in the journalClinical Cancer Research, CUNY SPH Associate Professor Levi Waldron and colleagues resolved

Researcher helps define subtypes of ovarian cancer

by The City University of New YorkCredit: CC0 Public DomainIn a new paper published in the journalClinical Cancer Research, CUNY SPH Associate Professor Levi Waldron and colleagues resolved
AZD6738 found to slow some types of children's tumor growth in mouse models

AZD6738 found to slow some types of children's tumor growth in mouse models

by Bob Yirka , Medical XpressCredit: CC0 Public Domain(Medical Xpress)—A team of researchers from the U.S., Germany and Japan has found that the chemical AZD6738 was able to slow some childhood type t

AZD6738 found to slow some types of children's tumor growth in mouse models

by Bob Yirka , Medical XpressCredit: CC0 Public Domain(Medical Xpress)—A team of researchers from the U.S., Germany and Japan has found that the chemical AZD6738 was able to slow some childhood type t
Cellular origins of pediatric brain tumors identified

Cellular origins of pediatric brain tumors identified

by McGill UniversityCredit: CC0 Public DomainA research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado

Cellular origins of pediatric brain tumors identified

by McGill UniversityCredit: CC0 Public DomainA research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado
Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur
What breast cancer risk assessments can tell you

What breast cancer risk assessments can tell you

by Justin Stebbing,The ConversationCredit: Unsplash/CC0 Public DomainActress Olivia Munn recently shared on social media that she had undergone a double mastectomy after being diagnosed with&nbs

What breast cancer risk assessments can tell you

by Justin Stebbing,The ConversationCredit: Unsplash/CC0 Public DomainActress Olivia Munn recently shared on social media that she had undergone a double mastectomy after being diagnosed with&nbs
Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit
Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

byPennsylvania State UniversityMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteImmunotherapies that mobilize a pati

Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

byPennsylvania State UniversityMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteImmunotherapies that mobilize a pati
Researchers key to advance care planning with cancer clinical trial patients

Researchers key to advance care planning with cancer clinical trial patients

by University of Pennsylvania School of NursingConnie M. Ulrich, PhD, RN, FAAN, the Lillian S. Brunner Chair in Medical and Surgical Nursing at the University of Pennsylvania School of Nursing (P

Researchers key to advance care planning with cancer clinical trial patients

by University of Pennsylvania School of NursingConnie M. Ulrich, PhD, RN, FAAN, the Lillian S. Brunner Chair in Medical and Surgical Nursing at the University of Pennsylvania School of Nursing (P